Pharma Collaboration for Transparent Medical Information (phactMI) Benchmark Study: Trends, Drivers, Success Factors, and Value of Globalization in Medical Information.

Background: Over the past decade, biopharmaceutical companies have been progressively establishing global frameworks across their capabilities. It is well recognized that the Medical Information (MI) department is a key externally facing function that needs to maintain a consistent focus on optimizing its capabilities of addressing product medical inquiries worldwide.

Methods: In the United States, a consortium named Pharma Collaboration for Transparent Medical Information, phactMI, a collaboration of pharmaceutical company MI departments dedicated to supporting health care professionals in their commitment to provide quality patient care, has provided a forum to benchmark and share best practices across the companies.

A Theory on the Relativity of Factors Impacting the Utilization of Medical Information Services From the Pharmaceutical Industry.

Health care providers have many options for obtaining answers to their questions about pharmaceutical products. These options include drug information curators and aggregators such as ePocrates, WebMD, and Wikipedia, as well as professional journals. However, drug information obtained directly from a pharmaceutical company is arguably the best source of information regarding that company's medicine.